Entheon Biomedical Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 18, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Market Capitalization	1	1	1	2	32	31
Market Cap Growth	134.54%	109.89%	-66.67%	-94.44%	3.86%	-
Enterprise Value	1	1	0	2	28	29
Last Close Price	0.10	0.14	0.10	0.30	5.40	7.60
PS Ratio	-	-	2.36	9.35	-	-
PB Ratio	3.56	8.53	1.87	2.88	3.52	8.20
P/TBV Ratio	3.56	8.53	1.87	2.88	10.13	8.20
EV/Sales Ratio	-	-	0.84	8.04	-	-
Asset Turnover	-	-	0.43	0.04	-	-
Quick Ratio	21.16	3.54	4.11	4.67	2.24	4.00
Current Ratio	21.84	4.53	4.64	4.81	3.46	6.05
Return on Equity (ROE)	-110.91%	-137.90%	-64.49%	-42.66%	-125.03%	-231.39%
Return on Assets (ROA)	-67.20%	-70.93%	-33.41%	-41.88%	-71.06%	-44.49%
Return on Capital Employed (ROCE)	-90.80%	-228.90%	-99.10%	-585.80%	-90.80%	-43.80%
Earnings Yield	-24.74%	-25.63%	-50.77%	-480.67%	-27.87%	-14.27%
FCF Yield	-	-28.68%	-60.91%	-110.26%	-16.72%	-9.27%
Buyback Yield / Dilution	-73.57%	-30.96%	-	-8.85%	-97.83%	-543.78%

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.